NCT04583657

Brief Summary

This study has two objectives: 1) to check that the daily consumption of two eggs with a particular fatty acid pattern rich in n-3 polyunsaturated fatty acids (α-linolenic acid, docosahexaenoic acid), conjugated-linoleic acid and conjugated-linolenic acid is well tolerated by the consumer ; 2) to evaluate the effects of the consumption of these eggs on health parameters in subjects presenting a risk of developing a metabolic disorder. This monocentric study is an interventional, randomized, double-blind, control study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 3, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 12, 2020

Completed
Last Updated

October 12, 2020

Status Verified

October 1, 2020

Enrollment Period

11 months

First QC Date

September 3, 2020

Last Update Submit

October 5, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glycated haemoglobin (HbA1c)

    Glycated haemoglobin (HbA1c) in blood samples

    Change from baseline (visit 1) glycated haemoglobin at 3 months (Day 90, visit 4)

Secondary Outcomes (62)

  • Glucose

    baseline (visit 1), Day 30 (visit 2), Day 60 (visit 3) and Day 90 (last visit 4)

  • Insulin

    baseline (visit 1), Day 30 (visit 2), Day 60 (visit 3) and Day 90 (last visit 4)

  • Homeostatic model assessment (HOMA)

    baseline (visit 1), Day 30 (visit 2), Day 60 (visit 3) and Day 90 (last visit 4)

  • Quantitative insulin sensitivity check index (QUICKI)

    baseline (visit 1), Day 30 (visit 2), Day 60 (visit 3) and Day 90 (last visit 4)

  • Triglycerides

    baseline (visit 1), Day 30 (visit 2), Day 60 (visit 3) and Day 90 (last visit 4)

  • +57 more secondary outcomes

Study Arms (2)

Control

PLACEBO COMPARATOR

Consumption of two "classical eggs" per day during three months. The fatty acid pattern of those eggs is characterized by: total saturated fatty acid 34.25%, total monounsaturated fatty acid 47.68%, total n-6 polyunsaturated fatty acid 16.97%, total n-3 polyunsaturated fatty acid 1.10%.

Other: Eggs

Test

EXPERIMENTAL

Consumption of two test eggs per day during three months. These eggs are naturally enriched in n-3 polyunsaturated fatty acids, conjugated-linoleic acids and conjugated-linolenic acids (total saturated fatty acid 31.74%, total monounsaturated fatty acid 28.09%, total n-6 polyunsaturated fatty acid 16.07%, total n-3 polyunsaturated fatty acid 6.51%)

Other: Eggs

Interventions

EggsOTHER

Consumption of two eggs (control or test) per day during three months

ControlTest

Eligibility Criteria

Age35 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Woman or man, aged of 35 to 75 years
  • Abdominal obesity : waist circumference for men \> 94cm and \> 80cm for women
  • Practicing \< 2h of physical activity per week

You may not qualify if:

  • Uncontrolled systolic blood pressure \> 160/100mmHg
  • For premenopausal women: pregnant or lactating women
  • For menopausal women: less than 6 months of menopause
  • Perimenopausal women with symptoms
  • Type II diabetes (fasted glycaemia ≥ 126mg/dl or HbA1c ≥ 6.5%), Type I diabetes
  • Medical history or actual cardiovascular disease (myocardial infarction, angina, transient ischemic attack, lower limb arteriopathy)
  • Familial history of premature cardiovascular incident (in male first degree relative \< 55 years and in female first degree relative \< 65 years; myocardial infarction, angina, transient ischemic attack, lower limb arteriopathy)
  • Medical history or actual liver, pancreas, kidney, pulmonary or gastrointestinal problem
  • Thyroid disorder
  • Cancer \< 5 years before the screening visit
  • Smokers or who have stopped smoking within 6 months before the screening visit
  • Subject presenting allergy or food intolerance to eggs
  • Subjects with psychiatric problems and/or using antipsychotics
  • Drug addiction problem
  • Recent change of body weight \> 5kg (\< 3 months before the screening visit)
  • +14 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center of Investigation in Clinical Nutrition

Louvain-la-Neuve, 1348, Belgium

Location

MeSH Terms

Conditions

Obesity, AbdominalSedentary Behavior

Interventions

Eggs

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Yvan Larondelle, Prof

    Université Catholique de Louvain

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This monocentric study is an interventional, randomized, double-blind, controlled study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2020

First Posted

October 12, 2020

Study Start

May 20, 2019

Primary Completion

April 20, 2020

Study Completion

April 20, 2020

Last Updated

October 12, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations